Literature DB >> 16011214

Research governance: panacea or problem?

Ash Samanta1, Jo Samanta.   

Abstract

Clinical research must meet contemporary professional, legal and ethical standards. Research governance aims to improve quality whilst safeguarding the interests of the public. Research on humans is covered by several internationally recognised ethical codes designed to protect persons from the hazards of experimental treatment. However, to date there is no overarching statutory framework that regulates health and social care research, which is governed by common law principles. The recent European Union Clinical Trials Directive aims to harmonise regulation of clinical trials and protect the interest of study participants. Approval by the new Central Office for Research Ethics Committees (COREC) is now a mandatory requirement for research projects in the UK to ensure stringent ethical standards. Research that involves NHS patients, staff, resources or premises is subject to a framework for research governance that monitors performance and adverse incidents and delineates lines of responsibility and accountability. Researchers at all levels must be fully aware of these new initiatives and of their responsibilities. NHS organisations should acknowledge and commit to clinical research as an intrinsic component of high quality health service delivery.

Entities:  

Mesh:

Year:  2005        PMID: 16011214      PMCID: PMC4952207          DOI: 10.7861/clinmedicine.5-3-235

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  2 in total

1.  Mis-investigating alleged research misconduct can cause widespread, unpredictable damage.

Authors:  Edmund Hey; Iain Chalmers
Journal:  J R Soc Med       Date:  2010-04       Impact factor: 5.344

2.  Changes in the institutional review board submission process for multicenter research over 6 years.

Authors:  Monika Pogorzelska; Patricia W Stone; Elizabeth Gross Cohn; Elaine Larson
Journal:  Nurs Outlook       Date:  2010 Jul-Aug       Impact factor: 3.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.